---
layout: post
title: FDA approved fixed-dose combination elbasvir-grazoprevir (Zepatier) for treatment of chronic hepatitis C genotypes 1 or 4
date: 2016-05-16 10:00:00
---

![](/assets/images/fda-approved-fixed-dose-combination-elbasvir-grazoprevir-zepatier-for-treatment-of-chronic-hepatitis-c-genotypes-1-or-4.jpg)

On January 28, 2016, the fixed-dose combination elbasvir-grazoprevir (Zepatier) was approved by the United States FDA for the treatment of chronic hepatitis C genotypes 1 or 4 infection in adults..

[Visit Hepatitis C Online to learn more!](http://www.hepatitisc.uw.edu/page/treatment/drugs/elbasvir-grazoprevir)